Reprogramming mature human cells so they can become any cell type in the body is a key focus of the new Pluripotent Stem Cell Facility at Cincinnati Children’s Hospital Medical Center.

Fostering innovation to speed the improvement of health care is the goal of an $8.3 million grant to researchers at Cincinnati Children’s Hospital Medical Center.

On May 1, 2009, a group of local companies and organizations, including BIOSTART, Cincinnati Children’s, GCVA, Neyer Holdings, Queen City Angels and Taft Stettinius & Hollister LLP introduced Cincinnati Innovates. Dialed-In recently caught up with one of the principals behind the regional contest, Elizabeth Edwards, to get more details about the competition and get her insights on the importance of innovation today.

CINCINNATI—The University of Cincinnati (UC) and its affiliated health care partners will receive nearly $23 million from the National Institutes of Health (NIH) to bring innovations from the laboratory bench to the bedside and to applications within the community.

The five-year funding, awarded through the NIH’s institutional Clinical and Translational Science Awards (CTSA) program, will be used to support programming within UC’s Center for Clinical and Translational Science and Training (CCTST).